The DOI matches its Crossref record; 277 of the 277 references it cites were found in a registry or an index.
Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?
Open accessAbstract
1. Introduction 2 2. What is the significance of the shared structural properties of disease-associated protein fibrils? 3 2.1 Mechanism of amyloid fibril formation in vitro 6 2.1.1 In vitro fibril formation involves transient population of ordered aggregates of intermediate stability, or protofibrils 6 3. Toxic properties of protofibrils 7 3.1 Protofibrils, rather than fibrils, are likely to be pathogenic 7 3.2 The toxic protofibril may be a mixture of related species 8 3.3 Morphological similarities of protofibrils suggest a common mechanism of toxicity 9 3.4 Are the amyloid diseases a subset of a much larger class of previously unrecognized protofibril diseases? 9 3.5 Fibrils, in the form of aggresomes, may function to sequester toxic protofibrils 9 4. Amyloid pores, a common structural link among protein aggregation neurodegenerative diseases 10 4.1 Mechanistic studies of amyloid fibril formation reveal common features, including pore-like protofibrils 10 4.1.1 Amyloid-β (Aβ) (Alzheimer's disease) 10 4.1.2 α-Synuclein (PD and diffuse Lewy body disease) 12 4.1.3 ABri (familial British dementia) 13 4.1.4 Superoxide dismutase-1 (amyotrophic lateral sclerosis) 13 4.1.5 Prion protein (Creutzfeldt–Jakob disease, bovine spongiform encephalopathy, etc.) 14 4.1.6 Huntingtin (Huntington's disease) 14 4.2 Amyloidogenic proteins that are not linked to disease also from pore-like protofibrils 15 4.3 Amyloid proteins form non-fibrillar aggregates that have properties of protein channels or pores 15 4.3.1 Aβ ‘channels’ 15 4.3.2 α-Synuclein ‘pores’ 16 4.3.3 PrP ‘channels’ 16 4.3.4 Polyglutamine ‘channels’ 17 4.4 Nature uses β-strand-mediated protein oligomerization to construct pore-forming toxins 17 5. Mechanisms of protofibril induced toxicity in protein aggregation diseases 19 5.1 The amyloid pore can explain the age-association and cell-type selectivity of the neurodegenerative diseases 19 5.2 Protofibrils may promote their own accumulation by inhibiting the proteasome 20 6. Testing the amyloid pore hypothesis by attempting to disprove it 21 7. Acknowledgments 22 8. References 22 Protein fibrillization is implicated in the pathogenesis of most, if not all, age-associated neurodegenerative diseases, but the mechanism(s) by which it triggers neuronal death is unknown. Reductionist in vitro studies suggest that the amyloid protofibril may be the toxic species and that it may amplify itself by inhibiting proteasome-dependent protein degradation. Although its pathogenic target has not been identified, the properties of the protofibril suggest that neurons could be killed by unregulated membrane permeabilization, possibly by a type of protofibril referred to here as the ‘amyloid pore’. The purpose of this review is to summarize the existing supportive circumstantial evidence and to stimulate further studies designed to test the validity of this hypothesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 1×
“Disruption of Ca2+ homeostasis and generation of reactive oxygen species have long been re- cognized to be key events in the pathogenesis of several neurodegenerative diseases, including AD (Hardy & Higgins, 1992).”
BackgroundRosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434
Structure of Staphylococcal α-Hemolysin, a Heptameric Transmembrane Pore
Song, L., Hobaugh, M. R., Shustak, C., Cheley, S., Bayley, H., & Gouaux, J. E. (1996) · Science · doi:10.1126/science.274.5294.1859 · Cited by 2,377
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Self-citationAggresomes: A Cellular Response to Misfolded Proteins
Johnston, J. A., Ward, C. L., & Kopito, R. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.7.1883 · Cited by 2,148
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,132
A Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022 · cited 1×
“…increased propensity to aggregate and form annular protofibrils in vitro (H. Lashuel & P. T. Lansbury Jr., unpublished observations) as compared to Ab40, the predominant form ( Jarrett et al. 1993). b-sheet formation is also linked to Ab-channel formation (and aggregation) (Sanderson et al. 1997).”
BackgroundSelf-citationAggresomes, inclusion bodies and protein aggregation
Kopito, R. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01852-3 · Cited by 1,921
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Common core structure of amyloid fibrils by synchrotron X-ray diffraction 1 1Edited by F. E. Cohen
Sunde, M., Serpell, L. C., Bartlam, M., Fraser, P. E., Pepys, M. B., & Blake, C. C. F. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1348 · Cited by 1,707
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2005) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,687
Stefani, M., & Dobson, C. M. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0464-5 · Cited by 1,651
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650 · cited 2×
“The toxic protofibril hypothesis also explains features of PD and other neurodegenerative diseases that are inconsistent with the fibril being the pathogenic species (Goldberg & Lansbury, 2000 ; Caughey & Lansbury, 2003 ; Silveira et al. 2005).”
BackgroundSelf-citationThe ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
Conway, K. A., Lee, S.-J., Rochet, J.-C., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,541
Self-citationRapid degradation of a large fraction of newly synthesized proteins by proteasomes
Schubert, U., Antón, L. C., Gibbs, J., Norbury, C. C., Yewdell, J. W., & Bennink, J. R. (2000) · Nature · doi:10.1038/35008096 · Cited by 1,536
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
NACP, A Protein Implicated in Alzheimer's Disease and Learning, Is Natively Unfolded
Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A., & Lansbury, P. T. (1996) · Biochemistry · doi:10.1021/bi961799n · Cited by 1,523
Self-citationConway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,499
Self-citationAβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,498
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431
Glutamine Repeats and Neurodegeneration
Zoghbi, H. Y., & Orr, H. T. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.217 · Cited by 1,309
Amyloid pores from pathogenic mutations
Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T., & Lansbury, P. T. (2002) · Nature · doi:10.1038/418291a · Cited by 1,289
Self-citationCorrelation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268
Aggregation and Motor Neuron Toxicity of an ALS-Linked SOD1 Mutant Independent from Wild-Type SOD1
Bruijn, L. I., Houseweart, M. K., Kato, S., Anderson, K. L., Anderson, S. D., Ohama, E., Reaume, A. G., Scott, R. W., & Cleveland, D. W. (1998) · Science · doi:10.1126/science.281.5384.1851 · Cited by 1,228
The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation
Nilsberth, C., Westlind-Danielsson, A., Eckman, C. B., Condron, M. M., Axelman, K., Forsell, C., Stenh, C., Luthman, J., Teplow, D. B., Younkin, S. G., et al. (2001) · Nature Neuroscience · doi:10.1038/nn0901-887 · Cited by 1,209
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M., & Teplow, D. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22364 · Cited by 1,145
Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
Self-citationPlaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123 · cited 1×
“Second, transgenic animals that overproduce APP exhibit neuronal and behavioral abnormalities before amyloid plaques can be detected (Chui et al. 1999 ; Hsia et al. 1999 ; Moechars et al. 1999 ; Mucke et al. 2000).”
BackgroundAmyloid fibrillogenesis: themes and variations
Rochet, J.-C., & Lansbury, P. T. (2000) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)00049-4 · Cited by 1,095
Self-citationGong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834302100 · Cited by 1,061
Shimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. S., & Selkoe, D. J. (2001) · Science · doi:10.1126/science.1060627 · Cited by 1,053
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046
Demuro, A., Mina, E., Kayed, R., Milton, S. C., Parker, I., & Glabe, C. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500997200 · Cited by 1,041
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
Panov, A. V., Gutekunst, C.-A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2002) · Nature Neuroscience · doi:10.1038/nn884 · Cited by 1,030
Grazia Spillantini, M., Anthony Crowther, R., Jakes, R., Cairns, N. J., Lantos, P. L., & Goedert, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00504-7 · Cited by 1,025
In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis
Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210207200 · Cited by 1,015
The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways
Kelly, J. W. (1998) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(98)80016-x · Cited by 1,001
Amyloid ion channels: A common structural link for protein-misfolding disease
Quist, A., Doudevski, I., Lin, H., Azimova, R., Ng, D., Frangione, B., Kagan, B., Ghiso, J., & Lal, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502066102 · Cited by 982
The structural basis of protein folding and its links with human disease
Dobson, C. M. (2001) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2000.0758 · Cited by 932
Arispe, N., Rojas, E., & Pollard, H. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.567 · Cited by 926
Rosen, D. (1993) · Nature · doi:10.1038/364362c0 · Cited by 922
Kayed, R., Sokolov, Y., Edmonds, B., McIntire, T. M., Milton, S. C., Hall, J. E., & Glabe, C. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400260200 · Cited by 902
The most infectious prion protein particles
Silveira, J. R., Raymond, G. J., Hughson, A. G., Race, R. E., Sim, V. L., Hayes, S. F., & Caughey, B. (2005) · Nature · doi:10.1038/nature03989 · Cited by 899
Expanding insights of mitochondrial dysfunction in Parkinson's disease
Abou-Sleiman, P. M., Muqit, M. M. K., & Wood, N. W. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1868 · Cited by 869
Hartley, D. M., Walsh, D. M., Ye, C. P., Diehl, T., Vasquez, S., Vassilev, P. M., Teplow, D. B., & Selkoe, D. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08876.1999 · Cited by 817
Lashuel, H. A., Petre, B. M., Wall, J., Simon, M., Nowak, R. J., Walz, T., & Lansbury, P. T. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00735-0 · Cited by 805
Self-citationXu, J., Kao, S.-Y., Lee, F. J. S., Song, W., Jin, L.-W., & Yankner, B. A. (2002) · Nature Medicine · doi:10.1038/nm0602-600 · Cited by 757
Scherzinger, E., Sittler, A., Schweiger, K., Heiser, V., Lurz, R., Hasenbank, R., Bates, G. P., Lehrach, H., & Wanker, E. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4604 · Cited by 705
Volles, M. J., Lee, S.-J., Rochet, J.-C., Shtilerman, M. D., Ding, T. T., Kessler, J. C., & Lansbury, P. T. (2001) · Biochemistry · doi:10.1021/bi0102398 · Cited by 682
Self-citationMoechars, D., Dewachter, I., Lorent, K., Reversé, D., Baekelandt, V., Naidu, A., Tesseur, I., Spittaels, K., Haute, C. V. D., Checler, F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6483 · Cited by 668
THE BIOCHEMISTRY OF PARKINSON'S DISEASE
Cookson, M. R. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133400 · Cited by 664
Kirik, D., Rosenblad, C., Burger, C., Lundberg, C., Johansen, T. E., Muzyczka, N., Mandel, R. J., & Björklund, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02780.2002 · Cited by 649
Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology
LIN, H., BHATIA, R., & LAL, R. (2001) · The FASEB Journal · doi:10.1096/fj.01-0377com · Cited by 644
Townsend, M., Shankar, G. M., Mehta, T., Walsh, D. M., & Selkoe, D. J. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.103754 · Cited by 619
Water-soluble Aβ(N-40, N-42) oligomers in normal and Alzheimer disease brains
Kuo, Y.-M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J., & Roher, A. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4077 · Cited by 618
Chen, L., & Feany, M. B. (2005) · Nature Neuroscience · doi:10.1038/nn1443 · Cited by 618
Janson, J., Ashley, R. H., Harrison, D., McIntyre, S., & Butler, P. C. (1999) · Diabetes · doi:10.2337/diabetes.48.3.491 · Cited by 612
Johnston, J. A., Dalton, M. J., Gurney, M. E., & Kopito, R. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220417997 · Cited by 607
Lemere, C. A., Blusztajn, J. K., Yamaguchi, H., Wisniewski, T., Saido, T. C., & Selkoe, D. J. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0003 · Cited by 584 · cited 1×
“First, there is no correlation between the amounts of fibrillar Ab deposits at autopsy and the clinical severity of AD (Lemere et al. 1996 ; Terry et al. 1991).”
BackgroundSharon, R., Bar-Joseph, I., Frosch, M. P., Walsh, D. M., Hamilton, J. A., & Selkoe, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00024-2 · Cited by 562
Barghorn, S., Nimmrich, V., Striebinger, A., Krantz, C., Keller, P., Janson, B., Bahr, M., Schmidt, M., Bitner, R. S., Harlan, J., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03407.x · Cited by 559
Arispe, N., Pollard, H. B., & Rojas, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10573 · Cited by 557
PATHOLOGIC CONFORMATIONS OF PRION PROTEINS
Cohen, F. E., & Prusiner, S. B. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.793 · Cited by 533
Moore, R. C., Lee, I. Y., Silverman, G. L., Harrison, P. M., Strome, R., Heinrich, C., Karunaratne, A., Pasternak, S. H., Chishti, M. A., Liang, Y., et al. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3108 · Cited by 530
Wang, H.-W., Pasternak, J. F., Kuo, H., Ristic, H., Lambert, M. P., Chromy, B., Viola, K. L., Klein, W. L., Stine, W. B., Krafft, G. A., et al. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03058-x · Cited by 527
Li, J., Uversky, V. N., & Fink, A. L. (2001) · Biochemistry · doi:10.1021/bi010616g · Cited by 513
Bennett, E. J., Bence, N. F., Jayakumar, R., & Kopito, R. R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.021 · Cited by 509
Roher, A. E., Chaney, M. O., Kuo, Y.-M., Webster, S. D., Stine, W. B., Haverkamp, L. J., Woods, A. S., Cotter, R. J., Tuohy, J. M., Krafft, G. A., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20631 · Cited by 498
Tanaka, Y. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.9.919 · Cited by 497
Hoshi, M., Sato, M., Matsumoto, S., Noguchi, A., Yasutake, K., Yoshida, N., & Sato, K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1237107100 · Cited by 496
Volles, M. J., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi0121353 · Cited by 487
Self-citationNeurotoxicity and Neurodegeneration When PrP Accumulates in the Cytosol
Ma, J., Wollmann, R., & Lindquist, S. (2002) · Science · doi:10.1126/science.1073725 · Cited by 487
Lo Bianco, C., Ridet, J.-L., Schneider, B. L., Déglon, N., & Aebischer, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152339799 · Cited by 482
Shults, C. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509567103 · Cited by 476
The Flavonoid Baicalein Inhibits Fibrillation of α-Synuclein and Disaggregates Existing Fibrils
Zhu, M., Rajamani, S., Kaylor, J., Han, S., Zhou, F., & Fink, A. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403129200 · Cited by 473
A stop-codon mutation in the BRI gene associated with familial British dementia
Vidal, R., Frangione, B., Rostagno, A., Mead, S., Révész, T., Plant, G., & Ghiso, J. (1999) · Nature · doi:10.1038/21637 · Cited by 466
Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson’s disease?
Goldberg, M. S., & Lansbury Jr, P. T. (2000) · Nature Cell Biology · doi:10.1038/35017124 · Cited by 458
Harper, J. D., Wong, S. S., Lieber, C. M., & Lansbury, P. T. (1999) · Biochemistry · doi:10.1021/bi9904149 · Cited by 454
Self-citationHarper, J. D., Lieber, C. M., & Lansbury, P. T. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90303-3 · Cited by 453
Self-citationClearance of α-Synuclein Oligomeric Intermediates via the Lysosomal Degradation Pathway
Lee, H.-J., Khoshaghideh, F., Patel, S., & Lee, S.-J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3809-03.2004 · Cited by 445
Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin
Mirzabekov, T. A., Lin, M.-C., & Kagan, B. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.1988 · Cited by 442
Pathway Complexity of Prion Protein Assembly into Amyloid
Baskakov, I. V., Legname, G., Baldwin, M. A., Prusiner, S. B., & Cohen, F. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111402200 · Cited by 438
Julien, J.-P. (2001) · Cell · doi:10.1016/s0092-8674(01)00244-6 · Cited by 434
Volles, M. J., & Lansbury, P. T. (2003) · Biochemistry · doi:10.1021/bi030086j · Cited by 433
Self-citationWatanabe, M., Dykes-Hoberg, M., Cizewski Culotta, V., Price, D. L., Wong, P. C., & Rothstein, J. D. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0443 · Cited by 431
Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein
Taylor, J. P. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg074 · Cited by 426
Snyder, H., Mensah, K., Theisler, C., Lee, J., Matouschek, A., & Wolozin, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208641200 · Cited by 420
Zhang, Y., McLaughlin, R., Goodyer, C., & LeBlanc, A. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110119 · Cited by 418
Butler, A. E., Janson, J., Soeller, W. C., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2304 · Cited by 411
Kirik, D., Annett, L. E., Burger, C., Muzyczka, N., Mandel, R. J., & Björklund, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0536383100 · Cited by 403
The Oligomerization of Amyloid β-Protein Begins Intracellularly in Cells Derived from Human Brain
Walsh, D. M., Tseng, B. P., Rydel, R. E., Podlisny, M. B., & Selkoe, D. J. (2000) · Biochemistry · doi:10.1021/bi001048s · Cited by 401
β-Synuclein Inhibits α-Synuclein Aggregation
Hashimoto, M., Rockenstein, E., Mante, M., Mallory, M., & Masliah, E. (2001) · Neuron · doi:10.1016/s0896-6273(01)00462-7 · Cited by 398
Proteasomal Inhibition by α-Synuclein Filaments and Oligomers
Lindersson, E., Beedholm, R., Højrup, P., Moos, T., Gai, W., Hendil, K. B., & Jensen, P. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306390200 · Cited by 397
Pathology and Biology of the Lewy Body
Pollanen, M. S., Dickson, D. W., & Bergeron, C. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199305000-00001 · Cited by 396
Reixach, N., Deechongkit, S., Jiang, X., Kelly, J. W., & Buxbaum, J. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400062101 · Cited by 392
Hayward, L. J., Rodriguez, J. A., Kim, J. W., Tiwari, A., Goto, J. J., Cabelli, D. E., Valentine, J. S., & Brown, R. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112087200 · Cited by 377
Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., & Selkoe, D. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9564 · Cited by 370
Huntingtin Spheroids and Protofibrils as Precursors in Polyglutamine Fibrilization
Poirier, M. A., Li, H., Macosko, J., Cai, S., Amzel, M., & Ross, C. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205809200 · Cited by 367
On the mechanism of membrane damage by Staphylococcus aureus alpha-toxin.
Füssle, R., Bhakdi, S., Sziegoleit, A., Tranum-Jensen, J., Kranz, T., & Wellensiek, H. J. (1981) · The Journal of cell biology · doi:10.1083/jcb.91.1.83 · Cited by 366
Chui, D.-H., Tanahashi, H., Ozawa, K., Ikeda, S., Checler, F., Ueda, O., Suzuki, H., Araki, W., Inoue, H., Shirotani, K., et al. (1999) · Nature Medicine · doi:10.1038/8438 · Cited by 364
Huntington aggregates may not predict neuronal death in Huntington's disease.
Kuemmerle, S., Gutekunst, C., Klein, A., Li, X. J., Li, S. H., Beal, M. F., Hersch, S. M., & Ferrante, R. J. (1999) · PubMed · Cited by 362
Watase, K., Weeber, E. J., Xu, B., Antalffy, B., Yuva-Paylor, L., Hashimoto, K., Kano, M., Atkinson, R., Sun, Y., Armstrong, D. L., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00733-x · Cited by 359
Ding, T. T., Lee, S.-J., Rochet, J.-C., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi020139h · Cited by 356
Self-citationVaccination with soluble Aβ oligomers generates toxicity‐neutralizing antibodies
Lambert, M. P., Viola, K. L., Chromy, B. A., Chang, L., Morgan, T. E., Yu, J., Venton, D. L., Krafft, G. A., Finch, C. E., & Klein, W. L. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00592.x · Cited by 349
Deposition of Transthyretin in Early Stages of Familial Amyloidotic Polyneuropathy
Mendes Sousa, M., Cardoso, I., Fernandes, R., Guimarães, A., & Saraiva, M. J. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63050-7 · Cited by 344
Rakhit, R., Crow, J. P., Lepock, J. R., Kondejewski, L. H., Cashman, N. R., & Chakrabartty, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313295200 · Cited by 344
Structural and functional imaging with carbon nanotube AFM probes
Hafner, J. H., Cheung, C.-L., Woolley, A. T., & Lieber, C. M. (2001) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(01)00011-6 · Cited by 344
Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.
Janson, J., Soeller, W. C., Roche, P. C., Nelson, R. T., Torchia, A. J., Kreutter, D. K., & Butler, P. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7283 · Cited by 342
The protofilament substructure of amyloid fibrils11Edited by F. E. Cohen
Serpell, L. C., Sunde, M., Benson, M. D., Tennent, G. A., Pepys, M. B., & Fraser, P. E. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3908 · Cited by 342
Rakhit, R., Cunningham, P., Furtos-Matei, A., Dahan, S., Qi, X.-F., Crow, J. P., Cashman, N. R., Kondejewski, L. H., & Chakrabartty, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207356200 · Cited by 333
Conformational Abs recognizing a generic amyloid fibril epitope
O'Nuallain, B., & Wetzel, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022662599 · Cited by 333
Pitschke, M., Prior, R., Haupt, M., & Riesner, D. (1998) · Nature Medicine · doi:10.1038/nm0798-832 · Cited by 328
Sharon, R., Goldberg, M. S., Bar-Josef, I., Betensky, R. A., Shen, J., & Selkoe, D. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171300598 · Cited by 328
Elam, J. S., Taylor, A. B., Strange, R., Antonyuk, S., Doucette, P. A., Rodriguez, J. A., Hasnain, S. S., Hayward, L. J., Valentine, J. S., Yeates, T. O., et al. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb935 · Cited by 316
Protein Misfolding, Amyloid Formation, and Neurodegeneration
Muchowski, P. J. (2002) · Neuron · doi:10.1016/s0896-6273(02)00761-4 · Cited by 308
Transmissible and genetic prion diseases share a common pathway of neurodegeneration
Hegde, R. S., Tremblay, P., Groth, D., DeArmond, S. J., Prusiner, S. B., & Lingappa, V. R. (1999) · Nature · doi:10.1038/45574 · Cited by 307
McNaught, K. S. P., Mytilineou, C., JnoBaptiste, R., Yabut, J., Shashidharan, P., Jenner, P., & Olanow, C. W. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00821.x · Cited by 304
Gosavi, N., Lee, H.-J., Lee, J. S., Patel, S., & Lee, S.-J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208194200 · Cited by 294
Kawahara, M., Kuroda, Y., Arispe, N., & Rojas, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14077 · Cited by 294
Anguiano, M., Nowak, R. J., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi020314u · Cited by 293
Self-citationShibata, N., Hirano, A., Kobayashi, M., Siddique, T., Deng, H.-X., Hung, W.-Y., Kato, T., & Asayama, K. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199604000-00011 · Cited by 293
Formation and Removal of α-Synuclein Aggregates in Cells Exposed to Mitochondrial Inhibitors
Lee, H.-J., Shin, S. Y., Choi, C., Lee, Y. H., & Lee, S.-J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105326200 · Cited by 291
Conversion of PrP to a Self-Perpetuating PrP Sc -like Conformation in the Cytosol
Ma, J., & Lindquist, S. (2002) · Science · doi:10.1126/science.1073619 · Cited by 287
Wacker, J. L., Zareie, M. H., Fong, H., Sarikaya, M., & Muchowski, P. J. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb860 · Cited by 283
Shtilerman, M. D., Ding, T. T., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi0120906 · Cited by 281
Self-citationProtein quality control: chaperones culling corrupt conformations
McClellan, A. J., Tam, S., Kaganovich, D., & Frydman, J. (2005) · Nature Cell Biology · doi:10.1038/ncb0805-736 · Cited by 280
Multiple Assembly Pathways Underlie Amyloid-β Fibril Polymorphisms
Goldsbury, C., Frey, P., Olivieri, V., Aebi, U., & Müller, S. A. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.07.029 · Cited by 273
Urushitani, M., Kurisu, J., Tsukita, K., & Takahashi, R. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01211.x · Cited by 268
-Synuclein Phosphorylation Enhances Eosinophilic Cytoplasmic Inclusion Formation in SH-SY5Y Cells
Smith, W. W. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0482-05.2005 · Cited by 268
Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain
Rossi, D. (2001) · The EMBO Journal · doi:10.1093/emboj/20.4.694 · Cited by 264
Mutations and off-pathway aggregation of proteins
Wetzel, R. (1994) · Trends in Biotechnology · doi:10.1016/0167-7799(94)90082-5 · Cited by 262
The ubiquitin–proteasome pathway in Parkinson's disease and other neurodegenerative diseases
Ross, C. A., & Pickart, C. M. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.10.006 · Cited by 261
Altered proteasome structure, function, and oxidation in aged muscle.
Ferrington, D. A., Husom, A. D., & Thompson, L. V. (2005) · The FASEB Journal · doi:10.1096/fj.04-2578fje · Cited by 259
Li, J., Zhu, M., Manning-Bog, A. B., Di Monte, D. A., & Fink, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0770fje · Cited by 258
El-Agnaf, O. M. A., Jakes, R., Curran, M. D., & Wallace, A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01419-7 · Cited by 258
Zn2+ interaction with Alzheimer amyloid beta protein calcium channels.
Arispe, N., Pollard, H. B., & Rojas, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1710 · Cited by 256
Ben-Zvi, A. P., & Goloubinoff, P. (2001) · Journal of Structural Biology · doi:10.1006/jsbi.2001.4352 · Cited by 241
Rodriguez, J. A., Valentine, J. S., Eggers, D. K., Roe, J. A., Tiwari, A., Brown, R. H., & Hayward, L. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112088200 · Cited by 238
Specificity in intracellular protein aggregation and inclusion body formation
Rajan, R. S., Illing, M. E., Bence, N. F., & Kopito, R. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181479798 · Cited by 237
Are ubiquitination pathways central to Parkinson’s disease?
Giasson, B. I., & Lee, V. M.-Y. (2003) · Cell · doi:10.1016/s0092-8674(03)00509-9 · Cited by 234
The channel hypothesis of Alzheimer’s disease: current status
Kagan, B. L., Hirakura, Y., Azimov, R., Azimova, R., & Lin, M.-C. (2002) · Peptides · doi:10.1016/s0196-9781(02)00067-0 · Cited by 230
Bhatia, R., Lin, H., & Lal, R. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.9.1233 · Cited by 226
Kawahara, M., & Kuroda, Y. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00370-1 · Cited by 224
Tiwari, A., & Hayward, L. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210419200 · Cited by 224
Rochet, J.-C., Conway, K. A., & Lansbury, P. T. (2000) · Biochemistry · doi:10.1021/bi001315u · Cited by 222
Self-citationDifferential effects of oligomeric and fibrillar amyloid-β1–42 on astrocyte-mediated inflammation
White, J. A., Manelli, A. M., Holmberg, K. H., Van Eldik, L. J., & LaDu, M. J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.12.013 · Cited by 221
Kawahara, M., Arispe, N., Kuroda, Y., & Rojas, E. (1997) · Biophysical Journal · doi:10.1016/s0006-3495(97)78048-2 · Cited by 219
E. coli Hemolysin E (HlyE, ClyA, SheA)
Wallace, A. J., Stillman, T. J., Atkins, A., Jamieson, S. J., Bullough, P. A., Green, J., & Artymiuk, P. J. (2000) · Cell · doi:10.1016/s0092-8674(00)81564-0 · Cited by 214
Gambetti, P., Parchi, P., Petersen, R. B., Chen, S. G., & Lugaresi, E. (1995) · Brain Pathology · doi:10.1111/j.1750-3639.1995.tb00576.x · Cited by 213
Structural studies of soluble oligomers of the alzheimer β-amyloid peptide
Huang, T. H. J., Yang, D.-S., Plaskos, N. P., Go, S., Yip, C. M., Fraser, P. E., & Chakrabartty, A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3559 · Cited by 212
Selective neuronal degeneration induced by soluble oligomeric amyloid beta‐protein
Kim, H., Chae, S., Lee, D., Chromy, B., Cheol Lee, S., Park, Y., Klein, W. L., Krafft, G. A., & Hong, S. (2003) · The FASEB Journal · doi:10.1096/fj.01-0987fje · Cited by 210
Mitochondrial involvement in amyotrophic lateral sclerosis
Menzies, F. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00125-5 · Cited by 210
Supattapone, S., Bosque, P., Muramoto, T., Wille, H., Aagaard, C., Peretz, D., Nguyen, H.-O. B., Heinrich, C., Torchia, M., Safar, J., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80596-6 · Cited by 206
Lashuel, H. A., Lai, Z., & Kelly, J. W. (1998) · Biochemistry · doi:10.1021/bi981876+ · Cited by 206
Self-citationHierarchical Assembly of β2-Microglobulin Amyloid In Vitro Revealed by Atomic Force Microscopy
Kad, N. M., Myers, S. L., Smith, D. P., Alastair Smith, D., Radford, S. E., & Thomson, N. H. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00583-7 · Cited by 203
Curtain, C. C., Ali, F. E., Smith, D. G., Bush, A. I., Masters, C. L., & Barnham, K. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205455200 · Cited by 200
Fibrillar Aggregates of the Tumor Suppressor p53 Core Domain
Ishimaru, D., Andrade, L. R., Teixeira, L. S. P., Quesado, P. A., Maiolino, L. M., Lopez, P. M., Cordeiro, Y., Costa, L. T., Heckl, W. M., Weissmüller, G., et al. (2003) · Biochemistry · doi:10.1021/bi034218k · Cited by 196
Oligomerization and Toxicity of β-Amyloid-42 Implicated in Alzheimer's Disease
El-Agnaf, O. M. A., Mahil, D. S., Patel, B. P., & Austen, B. M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3051 · Cited by 195
Amyloid β Protein-(1–42) Forms Calcium-permeable, Zn2+-sensitive Channel
Rhee, S. K., Quist, A. P., & Lal, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13379 · Cited by 195
Lindberg, M. J., Tibell, L., & Oliveberg, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262527099 · Cited by 193
Neuronal vulnerability in Parkinson’s disease
Hirsch, E. C., Faucheux, B., Damier, P., Mouatt-Prigent, A., & Agid, Y. (1997) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-6842-4_9 · Cited by 192
Channel Formation by a Neurotoxic Prion Protein Fragment
Lin, M.-C., Mirzabekov, T., & Kagan, B. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.1.44 · Cited by 190
Sharon, R., Bar-Joseph, I., Mirick, G. E., Serhan, C. N., & Selkoe, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309127200 · Cited by 187
Binding of prion protein to lipid membranes and implications for prion conversion
Sanghera, N., & Pinheiro, T. J. T. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5322 · Cited by 186
Contribution of somal Lewy bodies to neuronal death
Tompkins, M. M., & Hill, W. D. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00874-3 · Cited by 183
Yong, W., Lomakin, A., Kirkitadze, M. D., Teplow, D. B., Chen, S.-H., & Benedek, G. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012584899 · Cited by 178
Berke, S. J. S., & Paulson, H. L. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00053-4 · Cited by 178
Lashuel, H. A., Wurth, C., Woo, L., & Kelly, J. W. (1999) · Biochemistry · doi:10.1021/bi991021c · Cited by 176
Self-citationThe Human Islet Amyloid Polypeptide Forms Transient Membrane-Active Prefibrillar Assemblies
Porat, Y., Kolusheva, S., Jelinek, R., & Gazit, E. (2003) · Biochemistry · doi:10.1021/bi034889i · Cited by 174
Amyotrophic Lateral Sclerosis: Clinical Features and Prognosis
Rosen, A. D. (1978) · Archives of Neurology · doi:10.1001/archneur.1978.00500340014003 · Cited by 173
Characterization of Cytoplasmic α-Synuclein Aggregates
Lee, H.-J., & Lee, S.-J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208192200 · Cited by 173
Lowe, R., Pountney, D. L., Jensen, P. H., Gai, W. P., & Voelcker, N. H. (2004) · Protein Science · doi:10.1110/ps.04879704 · Cited by 165
Altered expression of the synuclein family mRNA in Lewy body and Alzheimer’s disease
Rockenstein, E., Hansen, L. A., Mallory, M., Trojanowski, J. Q., Galasko, D., & Masliah, E. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02772-x · Cited by 164
Prion Diseases: What Is the Neurotoxic Molecule?
Chiesa, R., & Harris, D. A. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0433 · Cited by 160
Park, J.-Y., & Lansbury, P. T. (2003) · Biochemistry · doi:10.1021/bi020604a · Cited by 159
Self-citationKaylor, J., Bodner, N., Edridge, S., Yamin, G., Hong, D.-P., & Fink, A. L. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.08.046 · Cited by 159
Lin, H., Zhu, Y. J., & Lal, R. (1999) · Biochemistry · doi:10.1021/bi982997c · Cited by 159
Morishima‐Kawashima, M., & Ihara, Y. (1998) · Biochemistry · doi:10.1021/bi981843u · Cited by 158
The Molecular Chaperone αB-crystallin Enhances Amyloid β Neurotoxicity
Stege, G. J. J., Renkawek, K., Overkamp, P., Verschuure, P., van Rijk, A. F., Reijnen-Aalbers, A., Boelens, W. C., Bosman, G. J. C. G. M., & JONG, W. W. D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1167 · Cited by 158
Walker, B., Krishnasastry, M. V., Zorn, L. J., & Bayley, H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36680-3 · Cited by 157
Human Amylin Oligomer Growth and Fibril Elongation Define Two Distinct Phases in Amyloid Formation
Green, J. D., Goldsbury, C. S., Kistler, J., Cooper, G. J. S., & Aebi, U. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312452200 · Cited by 153
Alzheimer amyloid abeta1-42 channels: effects of solvent, pH, and Congo Red.
Hirakura, Y., Lin, M., & Kagan, B. L. (1999) · PubMed · Cited by 151
Brain membrane cholesterol domains, aging and amyloid beta-peptides
Wood, W. B., Schroeder, F., Igbavboa, U., Avdulov, N. A., & Chochina, S. V. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00018-0 · Cited by 149
Cited by
The proteostasis network and its decline in ageing
Hipp, M. S., Kasturi, P., & Hartl, F. U. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0101-y · Cited by 1,642
Functional amyloid – from bacteria to humans
Fowler, D. M., Koulov, A. V., Balch, W. E., & Kelly, J. W. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.03.003 · Cited by 1,059
Function and structure of inherently disordered proteins
Dunker, A. K., Silman, I., Uversky, V. N., & Sussman, J. L. (2008) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.10.002 · Cited by 963
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 882
Different Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding
Danzer, K. M., Haasen, D., Karow, A. R., Moussaud, S., Habeck, M., Giese, A., Kretzschmar, H., Hengerer, B., & Kostka, M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2617-07.2007 · Cited by 765
Metadata
- Authors
- Lashuel, H. A., & Lansbury, P. T.
- Venue
- Quarterly Reviews of Biophysics
- Publisher
- Cambridge University Press (CUP)
- Published
- 2006-05
- Volume
- 39
- Issue
- 2
- Pages
- 167-201
- ISSN
- 0033-5835 (ISSN-L)
- 1469-8994
- OpenAlex
- W2129583700
- Cited by
- 400
- References
- 277
- FWCI
- 17.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.